XERIS PHARMACEUTICALS INC
XERIS PHARMACEUTICALS INC (XERS) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 237 transactions totaling $37.9M, demonstrating a bullish sentiment with $25.0M in net insider flow. The most recent transaction on Feb 24, 2026 involved a transaction of 29,300 shares valued at $201.6K.
XERS Insider Activity Summary
Who Is Buying XERS Stock?
No significant insider buying has been recorded for XERS in the recent period.
Who Is Selling XERS Stock?
No significant insider selling has been recorded for XERS in the recent period.
Is XERIS PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for XERS is bullish with an Insider Alignment Score of 83/100 and a net flow of $25.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
XERS Frequently Asked Questions
Understanding XERS Insider Activity
Insider trading at XERIS PHARMACEUTICALS INC (XERS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading XERS stock, having executed 237 transactions in the past 90 days. The most active insider is Mgmt Iii, L.p. Deerfield (Executive), who has made 4 transactions totaling $11.3M.
Related Tools
Track XERIS PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at XERS file new Form 4 transactions